Search results for: 'cro ad plan clinical'

This market insight covers the challenges associated with the adoption of next-generation sequencing (NGS)-based testing for routine diagnostic use. Emerging applications for gene panel and whole exome sequencing are discussed. Best practices and guidance have been provided to attain coverage on newly launched tests through case study analysis. Tab...

06 Feb 2018  |  Global  |  Market Research

Growth Opportunities in Clinical Trial Data Management and eClinical Solutions Market, Forecast to 2020

Digitization Presents Opportunities for Unified Cloud-based Platform Solutions to Optimize Clinical Trial Workflows

Infographics

×

Key Issues Addressed

The global clinical trial IT market is expected to grow from $2.63 billion in 2016 to $4.29 billion in 2020 at a compound annual growth rate (CAGR) of more than 13.0%. North America will continue to hold the largest market share (by revenue) in 2017, followed by Europe. Increasing clinical trial activities in the emerging Asia-Pacific markets and r...

Despite the term patient centricity gaining currency in the industry, there is a degree of variability in a companies’ approach and strategic priorities. Frost & Sullivan sees digitization playing a critical role in transforming the clinical trial model from traditional, high-cost, and difficult-to-access centralized settings to more patient-centri...

17 Sep 2024  |  Global  |  Market Research

ADAS and AD Sensor Suite Strategies, Europe, 2024 2030

OEMs Strategies Will Drive Transformational Growth by Using LiDAR as a Primary Sensor with Cameras and Imaging Radar to Meet the Rise of Eyes-off Driving

Infographics

×

Key Issues Addressed

The global automotive industry is going through a transformation with the convergence of the connected, autonomous, shared, and electric (CASE) trends. Connectivity and autonomous driving (AD) features are leading this transformation. Globally, OEMs are looking to introduce various advanced driver assistance system (ADAS) features ranging from L0 t...

23 Aug 2018  |  Europe  |  Market Research

Western European Clinical Laboratory Services Market, Forecast to 2022

Clinical Labs to Transform into Health Information Companies and Increasingly Participate in Clinical Decision Support

Infographics

×

Key Issues Addressed

Diagnostics has inarguably become an integral part of healthcare system, moving from reactionary science to predictive science; playing a vital role throughout the care continuum. While rising burden of chronic diseases, drug-resistant diseases and the increasing proportion of elderly population are the organic growth drivers, the shift towards cre...

Clinical decision support systems (CDSS) provide actionable information for improving the decision making abilities of the health professionals. However, the traditional CDSS platforms have drawbacks such as alert fatigue, diagnostic errors, workflow disruptions that can have detrimental effect on patients health outcomes as well as healthcare prov...

China is one of the fastest growing healthcare markets in the world. Traditionally, healthcare services have been dominated by the public sector; however, 2014 onward, the trend reversed with greater private sector participation. China still faces a number of challenges: unequal distribution of healthcare resources across the country; lack of an ef...

09 Jun 2016  |  Global  |  Market Research

Analysis of the Radio Access Networks (RAN) Capacity Planning and Management Market

Need for Enhanced Network Utilization and Expected Deployment of 5G to Boost Market Growth

Infographics

×

As LTE continues to proliferate the world, network operators are challenged by the need to offer an enhanced quality of service and experience without increasing their operating expenditure. These issues can be mitigated by adopting solutions that plan the dimension of the RAN infrastructure with precision. Customer experience can be enhanced throu...

This research service provides revenue forecasts for CROs globally, by phase and market type, R&D spending trends of pharmaceutical and biotechnology companies and pipeline drugs and clinical trial trends by phase and region. For the purpose of this research service, the U.S. CRO markets include revenues derived from the preclinical and clinical...